chrX-1288522-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_172245.4(CSF2RA):āc.223A>Gā(p.Ser75Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.002 in 1,613,948 control chromosomes in the GnomAD database, including 67 homozygotes. There are 1,439 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin ClinVar.
Frequency
Consequence
NM_172245.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CSF2RA | NM_172245.4 | c.223A>G | p.Ser75Gly | missense_variant | 5/13 | ENST00000381529.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CSF2RA | ENST00000381529.9 | c.223A>G | p.Ser75Gly | missense_variant | 5/13 | 1 | NM_172245.4 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0103 AC: 1569AN: 152164Hom.: 30 Cov.: 32 AF XY: 0.00971 AC XY: 722AN XY: 74332
GnomAD3 exomes AF: 0.00296 AC: 743AN: 251178Hom.: 16 AF XY: 0.00211 AC XY: 286AN XY: 135742
GnomAD4 exome AF: 0.00112 AC: 1637AN: 1461666Hom.: 34 Cov.: 33 AF XY: 0.000961 AC XY: 699AN XY: 727146
GnomAD4 genome AF: 0.0104 AC: 1587AN: 152282Hom.: 33 Cov.: 32 AF XY: 0.00994 AC XY: 740AN XY: 74460
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 13, 2021 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 21, 2013 | Ser75Gly in exon 6 of CSF2RA: This variant is not expected to have clinical sign ificance because it has been identified in 3.3% (147/4406) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs149059494). - |
Surfactant metabolism dysfunction, pulmonary, 4 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at